The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COMIRNATY (Pfizer-BioNTech COVID-19 Vaccine) 0.3 mL syringes for individuals aged 12 and above. The contract has a potential value of $1,494.30 and a completion date of March 1, 2024. This award is under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a maximum value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Generated 5/30/24, 9:47 AM